StockNews.com upgraded shares of 22nd Century Group (NASDAQ:XXII – Free Report) from a sell rating to a hold rating in a research note released on Wednesday.
22nd Century Group Stock Performance
Shares of NASDAQ XXII opened at $0.57 on Wednesday. The firm has a market cap of $4.68 million, a PE ratio of -0.01 and a beta of 1.38. 22nd Century Group has a one year low of $0.53 and a one year high of $35.20. The firm has a fifty day moving average of $0.71 and a 200 day moving average of $12.43.
22nd Century Group (NASDAQ:XXII – Get Free Report) last issued its quarterly earnings results on Wednesday, May 15th. The biotechnology company reported ($1.72) earnings per share for the quarter, beating analysts’ consensus estimates of ($5.28) by $3.56. 22nd Century Group had a negative net margin of 275.12% and a negative return on equity of 380.39%. The firm had revenue of $6.47 million for the quarter, compared to analyst estimates of $7.86 million.
Institutional Investors Weigh In On 22nd Century Group
22nd Century Group Company Profile
22nd Century Group, Inc, a tobacco products company, engages in the sale and distribution of its own proprietary new reduced nicotine tobacco products. The company offers reduced nicotine content tobacco plants and very low nicotine combustible cigarette products. It also provides contract manufacturing services for conventional combustible tobacco products for third-party brands.
Read More
- Five stocks we like better than 22nd Century Group
- What is the S&P 500 and How It is Distinct from Other Indexes
- Bumble’s Valuation Hits an All-Time Low, Can Its Fortunes Change?
- What Does a Stock Split Mean?
- MarketBeat Week in Review – 8/12 – 8/16
- Why Understanding Call Option Volume is Essential to Successful Options Trading
- JD.com Earnings Surprise: China’s Outlook Better Than Expected
Receive News & Ratings for 22nd Century Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for 22nd Century Group and related companies with MarketBeat.com's FREE daily email newsletter.